Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.
  • Page:
  • 1
  • 2

RENOVO, TRADING 30% BELOW CASH (RNVO)     

andyeds - 04 Jul 2008 16:31

Anyone else in Renovo?

49p of cash, trading at 35p.

If Juvista is approved later this year then license fee of $825m in the bank
(approx 7 x current share price)

Rest of the pipeline thrown in for nothing...

andyeds - 08 Jul 2008 16:53 - 2 of 29

now trading at 35% discount to cash, surely cheaper for Shire to take them out, rather than pay the extra $700m + royalties?

market cap=56m

luap5 - 08 Jul 2008 18:59 - 3 of 29

hi fella,lucky ol me ? im in renovo 30k of them sinse
end of march paid 37.9p.watched them fall to 27p but no balls
to top up.thought they might surge on when they reached
40p aweek or so ago.wishfull thinking!unlike u my knowledge
is very limited [only started this in feb. and thus far been a
painfull and costly initiation]might top up if they keep falling
every dog has its day i hope

goldfinger - 08 Jul 2008 19:17 - 4 of 29

Andy, I just hope they dont go 'tits up'.

I think youl get my drift, im sure.

cheers GF.

mitzy - 08 Feb 2009 19:02 - 5 of 29

I reckon is worth 40p gf do you still hold..?


Chart.aspx?Provider=EODIntra&Code=RNVO&S

goldfinger - 09 Feb 2009 00:28 - 6 of 29

Nope mitzy.

mitzy - 09 Feb 2009 08:27 - 7 of 29

Moving ahead maybe 30p later today.

mitzy - 09 Feb 2009 15:31 - 8 of 29

Cash in the bank is worth 60p so 40p could well be possible.

Andy - 02 Sep 2010 22:31 - 9 of 29

The directors of Biocompatibles (LSE: BII), Silence Therapeutics (AIM: SLN), Renovo Group Plc (LSE: RNVO) and smartFOCUS Group (AIM: STF) will be presenting:
Thursday the 9th September 2010, Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapand wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:
Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

Register here - http://www.proactiveinvestors.co.uk/register/event_details/87

If you have any problems registering or queries please email events@proactiveinvestors.com.

gibby - 11 Feb 2011 12:46 - 10 of 29

i was wondering why this was reversing today - i hope people did not get too burnt and lost only profit

was considering rnvo myself but after being tipped in the nationals left it after steep rises - sorry to any who lost here - very bad luck

gibby - 11 Feb 2011 13:01 - 11 of 29

imo this is way over done - dont they have cash in the bank worth at least 50p and other projects - i am in now! gla

gibby - 11 Feb 2011 13:04 - 12 of 29

a wave of blue lol!

gibby - 11 Feb 2011 13:11 - 13 of 29

dont forget:
Adaprev Reduction of adhesions following digital tendon injury Class III medical device in the EU.
Prevascar Reduction of skin scarring Phase 2

Juvidex Improve skin appearance and promote healing of damaged skin Cosmetic ingredient out-license

Adaprev Reduction of adhesions following digital tendon injury Class III medical device in the EU. Safety and preliminary performance (first of 2 trials for approval)

Prevascar Reduction of skin scarring Phase 2 - H1 2011 Proof of efficacy trial in
Juvidex Improve skin appearance and promote healing of damaged skin Cosmetic ingredient
&
RN1005
& cash in bank

gibby - 11 Feb 2011 13:14 - 14 of 29

yep they do have cash....

During the period the Company has continued to expend its cash balances developing its product portfolio. Renovos
combination of cash and cash equivalents with term deposits maturing within one year as at 31 December 2010 was
46.1 million, compared to the 51.8 million previously reported as at 30 September 2010. Renovos management
team believes that the Company is appropriately funded for continuing ongoing operations. As previously reported,
the net cash position, including investments, at the time of reporting the first Juvista EU Phase 3 trial in H1 2011 is
expected to be at least 30 million.

gibby - 11 Feb 2011 14:49 - 15 of 29

bouncing i believe!

driver - 11 Feb 2011 15:19 - 16 of 29

Not another ASM

gibby - 11 Feb 2011 15:33 - 17 of 29

its going up - still cheap for now!!!!

driver - 11 Feb 2011 15:36 - 18 of 29

18p is below cash. 40m

BAYLIS - 11 Feb 2011 17:15 - 19 of 29

Chart.aspx?Provider=EODIntra&Code=RNVO&S

gibby - 11 Feb 2011 17:25 - 20 of 29

driver -hello dude - yep 18p is below cash and they have other projects - may also make them a t/o target - now it has got interesting gonna find out more over the weekend - i so nearly invested here but the darn newspaper report sent it skying and imo didnt leave enough margin for me - however made a little beer money here today and will watch closely monday - real shock to see rnvo tank - when i saw it i thought it must be an error but it werent, feel for any caught - personally hoping for a rebound anywhere in the 20 to 30p range then of course results of other trials as they come in - gl

gibby - 11 Feb 2011 17:25 - 21 of 29

bayliss - that is one grim chart!!
  • Page:
  • 1
  • 2
Register now or login to post to this thread.